153 related articles for article (PubMed ID: 10512614)
1. NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)- pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV.
Hughes TE; Mone MD; Russell ME; Weldon SC; Villhauer EB
Biochemistry; 1999 Sep; 38(36):11597-603. PubMed ID: 10512614
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV inhibitor NVP-DPP728 ameliorates early insulin response and glucose tolerance in aged rats but not in aged Fischer 344 rats lacking its enzyme activity.
Mitani H; Takimoto M; Kimura M
Jpn J Pharmacol; 2002 Apr; 88(4):451-8. PubMed ID: 12046989
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity.
Mitani H; Takimoto M; Hughes TE; Kimura M
Jpn J Pharmacol; 2002 Apr; 88(4):442-50. PubMed ID: 12046988
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
Ahrén B; Simonsson E; Larsson H; Landin-Olsson M; Torgeirsson H; Jansson PA; Sandqvist M; Båvenholm P; Efendic S; Eriksson JW; Dickinson S; Holmes D
Diabetes Care; 2002 May; 25(5):869-75. PubMed ID: 11978683
[TBL] [Abstract][Full Text] [Related]
5. Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.
Deacon CF; Wamberg S; Bie P; Hughes TE; Holst JJ
J Endocrinol; 2002 Feb; 172(2):355-62. PubMed ID: 11834453
[TBL] [Abstract][Full Text] [Related]
6. 1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
Villhauer EB; Brinkman JA; Naderi GB; Dunning BE; Mangold BL; Mone MD; Russell ME; Weldon SC; Hughes TE
J Med Chem; 2002 Jun; 45(12):2362-5. PubMed ID: 12036346
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile).
Brandt I; Joossens J; Chen X; Maes MB; Scharpé S; De Meester I; Lambeir AM
Biochem Pharmacol; 2005 Jul; 70(1):134-43. PubMed ID: 15907807
[TBL] [Abstract][Full Text] [Related]
8. K579, a slow-binding inhibitor of dipeptidyl peptidase IV, is a long-acting hypoglycemic agent.
Takasaki K; Iwase M; Nakajima T; Ueno K; Nomoto Y; Nakanishi S; Higo K
Eur J Pharmacol; 2004 Feb; 486(3):335-42. PubMed ID: 14985056
[TBL] [Abstract][Full Text] [Related]
9. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
Reimer MK; Holst JJ; Ahrén B
Eur J Endocrinol; 2002 May; 146(5):717-27. PubMed ID: 11980629
[TBL] [Abstract][Full Text] [Related]
10. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
Villhauer EB; Brinkman JA; Naderi GB; Burkey BF; Dunning BE; Prasad K; Mangold BL; Russell ME; Hughes TE
J Med Chem; 2003 Jun; 46(13):2774-89. PubMed ID: 12801240
[TBL] [Abstract][Full Text] [Related]
11. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats.
Balkan B; Kwasnik L; Miserendino R; Holst JJ; Li X
Diabetologia; 1999 Nov; 42(11):1324-31. PubMed ID: 10550416
[TBL] [Abstract][Full Text] [Related]
13. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
14. 1-((S)-gamma-substituted prolyl)-(S)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors.
Sakashita H; Kitajima H; Nakamura M; Akahoshi F; Hayashi Y
Bioorg Med Chem Lett; 2005 May; 15(10):2441-5. PubMed ID: 15863294
[TBL] [Abstract][Full Text] [Related]
15. The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats.
Furrer D; Kaufmann K; Tschuor F; Reusch CE; Lutz TA
Vet J; 2010 Mar; 183(3):355-7. PubMed ID: 19128990
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.
Sudre B; Broqua P; White RB; Ashworth D; Evans DM; Haigh R; Junien JL; Aubert ML
Diabetes; 2002 May; 51(5):1461-9. PubMed ID: 11978643
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo.
Someya Y; Tahara A; Nakano R; Matsuyama-Yokono A; Nagase I; Fukunaga Y; Takasu T; Hayakawa M; Shibasaki M
Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):209-17. PubMed ID: 18398600
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic.
Zhao K; Lim DS; Funaki T; Welch JT
Bioorg Med Chem; 2003 Jan; 11(2):207-15. PubMed ID: 12470715
[TBL] [Abstract][Full Text] [Related]
19. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.
Thomas L; Eckhardt M; Langkopf E; Tadayyon M; Himmelsbach F; Mark M
J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196
[TBL] [Abstract][Full Text] [Related]
20. 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity.
Yamazaki K; Yasuda N; Inoue T; Nagakura T; Kira K; Shinoda M; Saeki T; Tanaka I
J Pharmacol Exp Ther; 2006 Dec; 319(3):1253-7. PubMed ID: 16980568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
